ArticleActa pharmaceutica Sinica. B2022

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy.

Jiayi Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.